The development of bone metastases is a complex pathological process in which tumor cells promote osteoclast overactivation through the secretion of multiple cytokines (such as PTHrP, IL-6, and TNF-α), thereby disrupting bone homeostasis and resulting in osteolytic, osteoblastic, or mixed bone lesions (5, 6). This evidence concerns the gene PTHLH and neoplasm.